Dow Development Laboratories (DDL)

Petaluma, CA
Topical Drug Products (semi-solids: creams, gels, ointments, pastes) Non-sterile Liquid Drug Products (solutions, suspensions) Small Molecule (topical) Peptides (topical) Proteins (topical) Oligonucleotides (topical) Medical Devices (topical)
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Dow Development Laboratories (DDL)

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Petaluma, CA
Modalities
Topical Drug Products (semi-solids: creams, gels, ointments, pastes), Non-sterile Liquid Drug Products (solutions, suspensions), Small Molecule (topical), Peptides (topical), Proteins (topical), Oligonucleotides (topical), Medical Devices (topical)
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Dow Development Laboratories (DDL)

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesTopical Drug Products (semi-solids: creams, gels, ointments, pastes), Non-sterile Liquid Drug Products (solutions, suspensions), Small Molecule (topical), Peptides (topical), Proteins (topical), Oligonucleotides (topical), Medical Devices (topical)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (7 modalities)

Frequently Asked Questions About Dow Development Laboratories (DDL)

What is Dow Development Laboratories (DDL)'s CDMO Signal Score?
Dow Development Laboratories (DDL) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Dow Development Laboratories (DDL) for a manufacturing program?
Use the free AI matchmaker to compare Dow Development Laboratories (DDL) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Oligonucleotides (topical) CDMOs →